Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans

Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans

This prospective study investigated the impact of lamivudine-containing antiretroviral therapy (ART) on HIV-positive patients in South Africa with baseline hepatitis B virus (HBV) infection. Follow-up samples from 56 HBV/HIV co-infected patients, 25 with occult HBV infection (OBI) and 31 with chroni...

Full description

Bibliographic Details
Main Authors:	Azwidowi Lukhwareni, Maemu Petronella Gededzha, Edina Amponsah-Dacosta, Jason T. Blackard, Rosemary J. Burnett, Selokela Gloria Selabe, Thanda Kyaw, M. Jeffrey Mphahlele
Format:	Article
Language:	English
Published:	MDPI AG 2020-06-01
Series:	Viruses
Subjects:	lamivudine antiretroviral therapy (ART) hepatitis B virus (HBV) HIV coinfection South Africa.
Online Access:	https://www.mdpi.com/1999-4915/12/6/634

Similar Items

Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis
by: Aoran Luo, et al.
Published: (2018-09-01)

Lamivudine for chronic hepatitis B: a brief review
by: Emilio Palumbo

Mutation Pattern of Lamivudine Resistance in Relation to Hepatitis B Genotypes
by: Damerow, Hans
Published: (2012)

Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection
by: Keeffe Emmet B, et al.
Published: (2005-09-01)

The efficacy of lamivudine in the treatment of reactivation of chronic hepatitis B virus infection in patients on immunosuppressive therapy
by: Delić Dragan, et al.
Published: (2011-01-01)

Antiviral therapy against chronic hepatitis B in Brazil: high rates of lamivudine resistance mutations and correlation with HBV genotypes
by: Francisco Campello do Amaral Mello, et al.
Published: (2012-05-01)

Effectiveness of add-on Pegylated interferon alfa-2a therapy in a Lamivudine-treated patient with chronic hepatitis B
by: Mangano Carmelo, et al.
Published: (2011-01-01)

Prevalence and mutational patterns of lamivudine-resistant HBV strains in chronically infected Serbian patients
by: Lazarević Ivana, et al.
Published: (2014-01-01)

Towards the complete eradication of mother-to-child HIV/HBV coinfection at Saint Camille Medical Centre in Burkina Faso, Africa
by: Denise Ilboudo, et al.

Hepatitis B and asymptomatic malaria coinfection in Sub-Saharan African immigrants: epidemiological and clinical features of HBV infection
by: Gaetano Scotto, et al.

Hepatitis B virus genotyping among chronic hepatitis B patients with resistance to treatment with lamivudine in the City of Ribeirão Preto, State of São Paulo Genotipagem do vírus da hepatite B de pacientes crônicos com resistência ao tratamento com lamivudina na Cidade de Ribeirão Preto, Estado de São Paulo
by: Rodrigo Haddad, et al.
Published: (2010-06-01)

Lamivudine: fading into the mists of time
by: Jonggi Choi, et al.
Published: (2017-12-01)

Lamivudine therapy for hepatitis B in renal transplantation
by: F.R.L. Santos, et al.
Published: (2002-02-01)

Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B
by: Chan Ho Park, et al.
Published: (2016-03-01)

High incidence and persistence of hepatitis B virus infection in individuals receiving HIV care in KwaZulu-Natal, South Africa
by: Nokukhanya Msomi, et al.
Published: (2020-11-01)

Is there Emergence of Clinical HBV Resistance Under Long-Term HBV Combination Therapy? A Challenging Case Report
by: Jürgen Kurt Rockstroh, et al.
Published: (2010-07-01)

Dolutegravir And Lamivudine Combination For The Treatment Of HIV-1 Infection
by: Zamora FJ, et al.
Published: (2019-10-01)

Treatment of chronic hepatitis B in Oman experience with lamivudine
by: Upadhyay Dip Amal, et al.
Published: (2003-01-01)

Detection of Mutations Resistant to Lamivudine or Adefovir in HBV and Its Management
by: Jia De-xing, et al.
Published: (2013-12-01)

Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study
by: Wu X, et al.
Published: (2019-04-01)

Lamivudine therapy for chronic hepatitis B in children: a meta-analysis
by: Aoran Luo, et al.
Published: (2019-07-01)

Effect of α-interferon combined with lamivudine on liver fibrosis in patients with CHB
by: Yong-Hua Wang, et al.
Published: (2016-12-01)

Experience with lamivudine treatment for severe acute hepatitis B
by: Verhaz Antonija
Published: (2014-01-01)

Prevalence of hepatitis B and delta according to HIV-type: a multi-country cross-sectional survey in West Africa
by: Patrick A. Coffie, et al.
Published: (2017-07-01)

The effects of prolonged Lamivudine administration as a sole treatment following the combination therapy of Interferon Alpha and Lamivudine in children for HBeAg (+) chronic hepatitis B
by: Sezin Asik Akman,1 Sabriye Cokceken Okcu,2 Sumer Sutcuoglu.2
Published: (2007-10-01)

Laboratory Evaluation of Three Regimens of Treatment of Chronic Hepatitis B: Tenofovir, Entecavir and Combination of Lamivudine and Adefovir
by: Rajeswari Jayakumar, et al.
Published: (2012-01-01)

Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients
by: Jeong Han Kim, et al.
Published: (2013-09-01)

Interactions of Tenofovir, Lamivudine, Abacavir and Didanosine in Primary Human Cells
by: Saye H. Khoo, et al.
Published: (2011-06-01)

HBV-INFECTION DE NOVO AFTER ORTHOTOPIC LIVER TRANSPLANTATION: CLINICAL AND VIROLOGICAL CHARACTERISTICS, ASSESSMENT OF ANTIVIRUS THERAPY EFFECTIVENESS
by: O. I. Malomuzh, et al.
Published: (2012-09-01)

Lamivudine’s hypersensitivity in an HIV infected patient: case report
by: Vitor R. G. A. Valviesse, et al.
Published: (2017-04-01)

Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir
by: EunYoung Ze, et al.
Published: (2014-09-01)

Unusual case of lamivudine-associated skin rashes in an HIV/AIDS patient: a case presentation
by: Kashif U Khan, et al.
Published: (2017-01-01)

Langzeiteffektivität der Therapie mit Lamivudin bei Patienten mit chronischer Hepatitis-B-Virus-Infektion – Prädiktion des Langzeitansprechens und Spektrum der Resistenzentwicklung
by: Brodzinski, Annika
Published: (2015)

Lack of Effect of Lamivudine on Ebola Virus Replication
by: Lisa Hensley, et al.
Published: (2015-03-01)

Cost-effectiveness of telbivudine versus lamivudine for chronic hepatitis B
by: Astrid Wiens, et al.

Seroprevalence of hepatitis B virus and hepatitis C virus co-infection among people living with HIV/AIDS visiting antiretroviral therapy centres in Nepal: a first nationally representative study
by: G. Ionita, et al.
Published: (2017-07-01)

Efficacy and safety on tenofovire therapy in patients with hepatitis B viral infections resistent to lamivudin
by: Katanić N., et al.
Published: (2015-01-01)

Rhabdomyolysis due to Lamivudine administration in acute viral hepatitis B infection: a case report from Malaysia
by: Janudin Baharin, et al.
Published: (2014-03-01)

HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA After Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort
by: Vincenzo Malagnino, et al.
Published: (2021-02-01)

Acute pancreatitis associated with lamivudine therapy for chronic B hepatitis
by: Felipe Francisco Tuon, et al.